No Matches Found
No Matches Found
No Matches Found
Sicagen India Ltd
Sicagen India Ltd Downgraded to Sell Amid Weak Technicals and Debt Concerns
Sicagen India Ltd, a player in the Trading & Distributors sector, has seen its investment rating downgraded from Hold to Sell as of 4 March 2026. This shift reflects deteriorating technical indicators, concerns over financial leverage, and subdued long-term growth prospects despite recent positive quarterly results. The company’s current Mojo Score stands at 46.0, signalling caution for investors amid a bearish outlook across multiple parameters.
Sicagen India Ltd Falls to 52-Week Low of Rs.47.11 Amid Market Pressure
Sicagen India Ltd’s shares declined to a fresh 52-week low of Rs.47.11 on 4 March 2026, marking a significant price level amid a broader market environment characterised by volatility and sectoral weakness. The stock has experienced a sustained downward trend over the past four trading sessions, culminating in a cumulative loss of 4.28% during this period.
Sicagen India Ltd Stock Falls to 52-Week Low of Rs.47.11
Sicagen India Ltd’s share price declined to a fresh 52-week low of Rs.47.11 on 4 March 2026, marking a significant milestone in the stock’s recent performance. The stock has been under pressure for the past four trading sessions, cumulatively falling by 4.28%, even as it marginally outperformed its sector on the day.
Sicagen India Ltd is Rated Hold
Sicagen India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 February 2026. While the rating change occurred earlier this month, the analysis and financial metrics discussed here reflect the company’s current position as of 26 February 2026, providing investors with the latest insights into its performance and outlook.
Sicagen India Ltd is Rated Hold by MarketsMOJO
Sicagen India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Sicagen India Ltd Upgraded to Hold as Financials Improve and Valuation Attracts
Sicagen India Ltd has seen its investment rating upgraded from Sell to Hold following a marked improvement in its financial performance, valuation metrics, and technical indicators. The company’s latest quarterly results, coupled with a more favourable market outlook, have driven this reassessment, signalling cautious optimism among investors.
Sicagen India Gains 5.37%: Key Financial Pressures and Recovery Signals
Sicagen India Ltd’s stock recorded a notable weekly gain of 5.37%, closing at Rs.54.59 on 30 Jan 2026, outperforming the Sensex’s 1.62% rise over the same period. The week was marked by a sharp recovery following a 52-week low and a quarterly earnings announcement that revealed modest growth amid ongoing margin pressures.
Sicagen India Ltd Reports Strong Quarterly Upswing Amid Financial Trend Shift
Sicagen India Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, shifting from a flat to a positive financial trend. The company recorded its highest quarterly net sales and profit after tax in recent history, signalling a potential turnaround amid a challenging trading and distribution sector backdrop.
Are Sicagen India Ltd latest results good or bad?
Sicagen India Ltd's latest results show strong revenue growth with net sales increasing by 14.69% year-on-year, but profitability is a concern as net profit remained stagnant and operating margins decreased. While there was a sequential improvement in profit in the following quarter, ongoing challenges in operational efficiency need to be addressed.
Sicagen India Q2 FY26: Modest Growth Masks Persistent Margin Pressures
Sicagen India Ltd., a Chennai-based trading and distribution company operating across building materials, power systems, and commercial vehicle dealerships, reported a mixed performance for Q2 FY26 (July-September 2025). Net profit remained flat at ₹4.14 crores compared to Q2 FY25, despite revenue growth of 14.69% year-on-year to ₹226.76 crores. The stock, with a market capitalisation of ₹207 crores, closed at ₹54.33 on January 30, 2026, gaining 6.15% on the day but remaining 34.92% below its 52-week high of ₹83.48.
Sicagen India Ltd Falls to 52-Week Low of Rs.49.8 Amidst Market Headwinds
Sicagen India Ltd’s shares declined to a fresh 52-week low of Rs.49.8 today, marking a significant downturn for the Trading & Distributors sector stock. The stock has underperformed both its sector and the broader market, reflecting ongoing concerns about its financial metrics and relative valuation.
When is the next results date for Sicagen India Ltd?
The next results date for Sicagen India Ltd is 30 January 2026.
Sicagen India Ltd is Rated Sell
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Sicagen India Ltd Falls to 52-Week Low Amidst Market Downturn
Sicagen India Ltd’s shares touched a fresh 52-week low of Rs.50.2 today, marking a significant decline amid broader market weakness and sectoral underperformance. The stock’s fall comes despite a slight outperformance relative to its sector, reflecting ongoing concerns about the company’s financial metrics and market positioning.
Sicagen India Ltd Falls to 52-Week Low of Rs.52.75 Amid Market Downturn
Sicagen India Ltd’s stock price declined to a fresh 52-week low of Rs.52.75 on 20 Jan 2026, marking a significant downturn amid broader market weakness and sectoral pressures. The stock has now recorded a three-day consecutive fall, losing 4.77% over this period, reflecting ongoing challenges within the Trading & Distributors sector.
Sicagen India Ltd is Rated Sell
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Sicagen India Ltd is Rated Sell
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Oct 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Sicagen India Ltd is Rated Sell
Sicagen India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 December 2025, providing investors with the latest insights into the company’s performance and outlook.
Sicagen India Stock Falls to 52-Week Low of Rs.53 Amid Market Pressure
Sicagen India has reached a new 52-week low of Rs.53, marking a significant decline amid a broader market environment where the Sensex trades near its yearly highs. The stock has experienced a three-day consecutive decline, reflecting ongoing pressures within the Trading & Distributors sector.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}

